EXIGER EXPLORERX Trademark

Trademark Overview


On Wednesday, June 21, 2023, a trademark application was filed for EXIGER EXPLORERX with the United States Patent and Trademark Office. The USPTO has given the EXIGER EXPLORERX trademark a serial number of 98053169. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, August 13, 2024. This trademark is owned by Exiger LLC. The EXIGER EXPLORERX trademark is filed in the Advertising, Business and Retail Services and Computer & Software Services & Scientific Services categories with the following description:

pharmaceutical supply chain transparency management provided through a web-based platform

Providing online, non-downloadable computer software platforms for use in database management in the field of pharmaceutical supply chain transparency; providing online, non-downloadable computer software platforms for use in mapping pharmaceutical ingredients to their chemical precursors; providing online, non-downloadable computer software platforms for use in tracking pharmaceutical suppliers, products and formulary risks to identify potential supply chain disruptions across the supplier ecosystem
exiger explorerx

General Information


Serial Number98053169
Word MarkEXIGER EXPLORERX
Filing DateWednesday, June 21, 2023
Status688 - NOTICE OF ALLOWANCE - ISSUED
Status DateTuesday, August 13, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 18, 2024

Trademark Statements


Pseudo MarkEXIGER EXPLORE RX
Goods and Servicespharmaceutical supply chain transparency management provided through a web-based platform
Goods and ServicesProviding online, non-downloadable computer software platforms for use in database management in the field of pharmaceutical supply chain transparency; providing online, non-downloadable computer software platforms for use in mapping pharmaceutical ingredients to their chemical precursors; providing online, non-downloadable computer software platforms for use in tracking pharmaceutical suppliers, products and formulary risks to identify potential supply chain disruptions across the supplier ecosystem

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateWednesday, May 15, 2024
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, July 24, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameExiger LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressNew York, NY 10169

Party NameExiger LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressNew York, NY 10169

Trademark Events


Event DateEvent Description
Saturday, June 24, 2023NEW APPLICATION ENTERED
Friday, March 8, 2024ASSIGNED TO EXAMINER
Monday, July 24, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, May 2, 2024NON-FINAL ACTION E-MAILED
Thursday, May 2, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, May 15, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, May 15, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, May 15, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 15, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, May 29, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 18, 2024PUBLISHED FOR OPPOSITION
Tuesday, June 18, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 13, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, May 2, 2024NON-FINAL ACTION WRITTEN